DOW JONES22,679.99+1627.46 7.73%
S&P 5002,663.68+175.03 7.03%
NASDAQ7,913.24+540.16 7.33%

Kindred Biosciences Q4 EPS $(0.4) Misses $(0.36) Estimate, Sales $1.401M Beat $1.3M Estimate

Kindred Biosciences (NASDAQ:KIN) reported quarterly losses of $(0.4) per share which missed the analyst consensus estimate of $(0.36) by 11.11 percent. This is a 13.04 percent increase over losses of $(0.46) per share

Benzinga · 03/16/2020 20:03

Kindred Biosciences (NASDAQ:KIN) reported quarterly losses of $(0.4) per share which missed the analyst consensus estimate of $(0.36) by 11.11 percent. This is a 13.04 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $1.401 million which beat the analyst consensus estimate of $1.3 million by 7.77 percent. This is a 5.66 percent increase over sales of $1.326 million the same period last year.